“Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy”. Global Journal of Science Frontier Research 24, no. G1 (November 14, 2024): 1–3. Accessed February 4, 2026. https://testing.journalofscience.org/index.php/GJSFR/article/view/102918.